Analysts expect AEON Biopharma, Inc. to report revenue of 0.00 for Q3 24, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 508,740.50 | 600,589.81 | 400,972.09 | 279,427.88 | 18.44 M | |||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 454,344.50 | 530,296.19 | 353,743.49 | 250,470.52 | 16.91 M | |||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 481,542.50 | 565,443.00 | 377,357.79 | 264,949.20 | 17.67 M |
Analysts expect AEON Biopharma, Inc. to report earnings per share of -0.08 for Q3 26, against a range of -0.08 to -0.08. The most recent reported quarter, Q2 26, came in at -0.02, a 91.7% beat against the -0.24 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -11.52 | 3.75 | 2.28 | -0.60 | -0.39 | -5.24 | -0.29 | -0.02 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -9.74 | -12.30 | -11.88 | -0.34 | -0.42 | -0.18 | -0.43 | -0.23 | -0.08 | -0.07 | -0.08 | -0.06 | 1.16 | 1.64 | -0.49 | -1.14 | ||||||||||
| Low Estimate | -11.74 | -14.38 | -14.10 | -0.40 | -0.48 | -0.20 | -0.49 | -0.25 | -0.08 | -0.09 | -0.10 | -0.06 | 1.08 | 1.38 | -0.59 | -1.30 | ||||||||||
| Consensus Estimate | -10.74 | -13.34 | -12.99 | -0.37 | -0.45 | -0.19 | -0.46 | -0.24 | -0.08 | -0.08 | -0.09 | -0.06 | 1.12 | 1.51 | -0.54 | -1.22 |